235 related articles for article (PubMed ID: 34445632)
1. 17,20S(OH)
Brown Lobbins ML; Scott IO; Slominski AT; Hasty KA; Zhang S; Miller DD; Li W; Kim TK; Janjetovic Z; Patel TS; Myers LK; Postlethwaite AE
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445632
[TBL] [Abstract][Full Text] [Related]
2. Modulation by 17,20S(OH)
Brown Lobbins ML; Slominski AT; Hasty KA; Zhang S; Miller DD; Li W; Kim TK; Janjetovic Z; Tuckey RC; Scott IO; Myers LK; Postlethwaite AE
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008794
[TBL] [Abstract][Full Text] [Related]
3. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
[TBL] [Abstract][Full Text] [Related]
4. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
5. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
6. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.
Karatas A; Celik C; Oz B; Akar ZA; Etem EO; Dagli AF; Koca SS
Int J Rheum Dis; 2021 Jun; 24(6):795-802. PubMed ID: 33835703
[TBL] [Abstract][Full Text] [Related]
7. Mouse model of dermal fibrosis induced by one-time injection of bleomycin-poly(L-lactic acid) microspheres.
Shibusawa Y; Negishi I; Tabata Y; Ishikawa O
Rheumatology (Oxford); 2008 Apr; 47(4):454-7. PubMed ID: 18316335
[TBL] [Abstract][Full Text] [Related]
8. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of adipose tissue-derived stem cells on bleomycin-induced mice of scleroderma].
Dou JL; Bai L; Pang CY; Zhang WL; Zhang W; Wang YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):970-976. PubMed ID: 27987499
[TBL] [Abstract][Full Text] [Related]
10. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
11. Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma.
Kajii M; Suzuki C; Kashihara J; Kobayashi F; Kubo Y; Miyamoto H; Yuuki T; Yamamoto T; Nakae T
Clin Exp Immunol; 2011 Feb; 163(2):235-41. PubMed ID: 21091669
[TBL] [Abstract][Full Text] [Related]
12. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.
Nakamura-Wakatsuki T; Oyama N; Yamamoto T
Exp Dermatol; 2012 Mar; 21(3):189-94. PubMed ID: 22188586
[TBL] [Abstract][Full Text] [Related]
13. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
[TBL] [Abstract][Full Text] [Related]
14. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
[TBL] [Abstract][Full Text] [Related]
15. A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.
Liang M; Lv J; Zou L; Yang W; Xiong Y; Chen X; Guan M; He R; Zou H
Lab Invest; 2015 Mar; 95(3):342-50. PubMed ID: 25502178
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice.
Song Y; Zhu L; Li M
Clinics (Sao Paulo); 2013 Oct; 68(10):1350-7. PubMed ID: 24212843
[TBL] [Abstract][Full Text] [Related]
17. 20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo.
Slominski A; Janjetovic Z; Tuckey RC; Nguyen MN; Bhattacharya KG; Wang J; Li W; Jiao Y; Gu W; Brown M; Postlethwaite AE
J Clin Endocrinol Metab; 2013 Feb; 98(2):E298-303. PubMed ID: 23295467
[TBL] [Abstract][Full Text] [Related]
18. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K
J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529
[TBL] [Abstract][Full Text] [Related]
19. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.
Castelino FV; Seiders J; Bain G; Brooks SF; King CD; Swaney JS; Lorrain DS; Chun J; Luster AD; Tager AM
Arthritis Rheum; 2011 May; 63(5):1405-15. PubMed ID: 21305523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]